Correlation Between Merck and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Moderna, you can compare the effects of market volatilities on Merck and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Moderna.

Diversification Opportunities for Merck and Moderna

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Merck and Moderna is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Merck i.e., Merck and Moderna go up and down completely randomly.

Pair Corralation between Merck and Moderna

Considering the 90-day investment horizon Merck Company is expected to generate 0.37 times more return on investment than Moderna. However, Merck Company is 2.72 times less risky than Moderna. It trades about 0.01 of its potential returns per unit of risk. Moderna is currently generating about -0.07 per unit of risk. If you would invest  9,930  in Merck Company on August 27, 2024 and sell it today you would lose (12.00) from holding Merck Company or give up 0.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Moderna

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Merck and Moderna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Moderna

The main advantage of trading using opposite Merck and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.
The idea behind Merck Company and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments